This is a free invitation-only event for Cheif Executive Officers, Non-Executive Directors and General Managers of BioMelbourne Network companies. If you feel another member of your company should attend, please contact Dr Kim Pham
This BioBriefing will address changes to the R&D tax incentive scheme following the May federal budget and the implications for the biotechnology, medical technology and pharmaceutical sector. In addition, the discussion will cover recent AusIndustry and ATO review activities and provide suggestions on how to manage the impact on your business.
Areas for discussion:
– Federal Budget announcements
– Recent AusIndustry and ATO review activities
– AusIndustry and ATO assessment frameworks
– Responding to an AusIndustry or ATO review
– R&D governance: how to improve your ability to defend your claims
Date: Thursday 10th May 2018
3:45pm – Registration
4:00pm – 5:20pm – Presentation and Discussion
5:20pm – Networking
Venue: KPMG, Level 37, Tower Two, Collins Square 727 Collins Street, Melbourne
Note: RSVPs are subject to confirmation by the BioMelbourne Network and limited to a maximum of 2 attendees per company.